Abbott Laboratories Statistics
Total Valuation
ABT has a market cap or net worth of $192.10 billion. The enterprise value is $197.30 billion.
| Market Cap | 192.10B |
| Enterprise Value | 197.30B |
Important Dates
The next estimated earnings date is Wednesday, April 15, 2026, before market open.
| Earnings Date | Apr 15, 2026 |
| Ex-Dividend Date | Apr 15, 2026 |
Share Statistics
ABT has 1.74 billion shares outstanding.
| Current Share Class | 1.74B |
| Shares Outstanding | 1.74B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | 0.49% |
| Owned by Institutions (%) | 81.12% |
| Float | 1.73B |
Valuation Ratios
The trailing PE ratio is 29.72 and the forward PE ratio is 19.47. ABT's PEG ratio is 2.01.
| PE Ratio | 29.72 |
| Forward PE | 19.47 |
| PS Ratio | 4.33 |
| Forward PS | 3.97 |
| PB Ratio | 3.68 |
| P/TBV Ratio | 8.51 |
| P/FCF Ratio | 25.98 |
| P/OCF Ratio | 20.08 |
| PEG Ratio | 2.01 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.40, with an EV/FCF ratio of 26.68.
| EV / Earnings | 30.35 |
| EV / Sales | 4.45 |
| EV / EBITDA | 16.40 |
| EV / EBIT | 22.13 |
| EV / FCF | 26.68 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.27.
| Current Ratio | 1.58 |
| Quick Ratio | 1.02 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 1.14 |
| Debt / FCF | 1.91 |
| Interest Coverage | 18.09 |
Financial Efficiency
Return on equity (ROE) is 12.96% and return on invested capital (ROIC) is 12.01%.
| Return on Equity (ROE) | 12.96% |
| Return on Assets (ROA) | 6.63% |
| Return on Invested Capital (ROIC) | 12.01% |
| Return on Capital Employed (ROCE) | 12.70% |
| Weighted Average Cost of Capital (WACC) | 7.95% |
| Revenue Per Employee | $385,461 |
| Profits Per Employee | $56,522 |
| Employee Count | 115,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 3.03 |
Taxes
In the past 12 months, ABT has paid $1.94 billion in taxes.
| Income Tax | 1.94B |
| Effective Tax Rate | 22.94% |
Stock Price Statistics
The stock price has decreased by -19.39% in the last 52 weeks. The beta is 0.74, so ABT's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | -19.39% |
| 50-Day Moving Average | 115.86 |
| 200-Day Moving Average | 126.64 |
| Relative Strength Index (RSI) | 42.22 |
| Average Volume (20 Days) | 8,535,478 |
Short Selling Information
The latest short interest is 17.20 million, so 0.99% of the outstanding shares have been sold short.
| Short Interest | 17.20M |
| Short Previous Month | 19.91M |
| Short % of Shares Out | 0.99% |
| Short % of Float | 1.00% |
| Short Ratio (days to cover) | 1.27 |
Income Statement
In the last 12 months, ABT had revenue of $44.33 billion and earned $6.50 billion in profits. Earnings per share was $3.72.
| Revenue | 44.33B |
| Gross Profit | 25.12B |
| Operating Income | 8.92B |
| Pretax Income | 8.47B |
| Net Income | 6.50B |
| EBITDA | 12.03B |
| EBIT | 8.92B |
| Earnings Per Share (EPS) | $3.72 |
Balance Sheet
The company has $8.94 billion in cash and $14.14 billion in debt, with a net cash position of -$5.20 billion or -$2.99 per share.
| Cash & Cash Equivalents | 8.94B |
| Total Debt | 14.14B |
| Net Cash | -5.20B |
| Net Cash Per Share | -$2.99 |
| Equity (Book Value) | 52.77B |
| Book Value Per Share | 30.02 |
| Working Capital | 9.50B |
Cash Flow
In the last 12 months, operating cash flow was $9.57 billion and capital expenditures -$2.17 billion, giving a free cash flow of $7.40 billion.
| Operating Cash Flow | 9.57B |
| Capital Expenditures | -2.17B |
| Free Cash Flow | 7.40B |
| FCF Per Share | $4.26 |
Margins
Gross margin is 56.66%, with operating and profit margins of 20.12% and 14.72%.
| Gross Margin | 56.66% |
| Operating Margin | 20.12% |
| Pretax Margin | 19.10% |
| Profit Margin | 14.72% |
| EBITDA Margin | 27.15% |
| EBIT Margin | 20.12% |
| FCF Margin | 16.68% |
Dividends & Yields
This stock pays an annual dividend of $2.52, which amounts to a dividend yield of 2.28%.
| Dividend Per Share | $2.52 |
| Dividend Yield | 2.28% |
| Dividend Growth (YoY) | 7.14% |
| Years of Dividend Growth | 54 |
| Payout Ratio | 64.52% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 2.22% |
| Earnings Yield | 3.38% |
| FCF Yield | 3.85% |
Analyst Forecast
The average price target for ABT is $140.24, which is 26.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $140.24 |
| Price Target Difference | 26.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 7.44% |
| EPS Growth Forecast (5Y) | 17.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 1, 1998. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 1, 1998 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
ABT has an Altman Z-Score of 5.76 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.76 |
| Piotroski F-Score | 6 |